The Invokana CANVAS study, mandated by the FDA as part of post-marketing requirements and sponsored by…

For some time, there has been concern over sodium-glucose transport-2 (SGLT-2) inhibitors such as Invokana (canagliflozin), Farxiga (…

In the wake of an FDA advisory on the link between Invokana (canagliflozin) and an elevated risk of lower limb amputations, a number of physicians and health care providers in California…

In May, Drug Safety News published a story about the association between…

This week, Johnson & Johnson was celebrating results from its CANVAS and CANVAS-R studies, showing that its diabetic drug Invokana (canagliflozin) reduced the risk of heart attacks and…

A recently published “real world” study of gliflozin drugs such as Invokana concluded…

When there is a sizable number of lawsuits against a company with similar causes of action, there is usually a movement to combine all of the trials so they are heard before one judge. It's a way…

It took far too long, but as of this past August, the warning label for the diabetic drug Invokana (canagliflozin) was finally…

While the diabetic medication Invokana (canagliflozin) has been implicated in the development ketoacidosis in patients, it is not the only prescription drug in its class to have such a…

Considering our government is bought and paid for by Big Pharma, it’s only fitting that Janssen Pharmaceuticals has used the Beltway’s time-honored “Friday news dump” to inform the public that its…